1795037-03-4
1795037-03-4
Chemical Structure
3-Methyl-2-oxovaleric acid-d8 sodium
- CAS No.: 1795037-03-4
- Formula:C6HD8NaO3
- Molecular Weight:160.17
InChIKey: SMDJDLCNOXJGKC-FIRJCWQZSA-M
SMILES: [2H]C([2H])([2H])C([2H])([2H])C(C([2H])([2H])[2H])C(C(O[Na])=O)=O
Biological Activity: 3-Methyl-2-oxovaleric acid-d8 sodium is the deuterium labeled 3-Methyl-2-oxovaleric acid. 3-Methyl-2-oxovaleric acid is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid is a biomarker of mustard airway diseases (MADs) and uric acid stone[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Methyl-2-oxovaleric acid-d8 sodium | 99.74% | 3-Methyl-2-oxovaleric acid-d8 sodium is the deuterium labeled 3-Methyl-2-oxovaleric acid. 3-Methyl-2-oxovaleric acid is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid is a biomarker of mustard airway diseases (MADs) and uric acid stone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyl-2-oxovaleric acid (Standard) | 99.86% | 3-Methyl-2-oxovaleric acid (Standard) is the analytical standard of 3-Methyl-2-oxovaleric acid (HY-113063). This product is intended for research and analytical applications. 3-Methyl-2-oxovaleric acid is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid is a biomarker of mustard airway diseases (MADs) and uric acid stone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyl-2-oxovaleric acid | 98.37% | 3-Methyl-2-oxovaleric acid is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid is a biomarker of mustard airway diseases (MADs) and uric acid stone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]
- [2]. Ghoochani BFNM, et, al. Metabolomics diagnostic approach to mustard airway diseases: a preliminary study. Iran J Basic Med Sci. 2018 Jan;21(1):59-69. [Content Brief]
